vs
Side-by-side financial comparison of AbbVie (ABBV) and Owlet, Inc. (OWLT). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($16.6B vs $26.6M, roughly 625.8× Owlet, Inc.). AbbVie runs the higher net margin — 10.9% vs -34.6%, a 45.5% gap on every dollar of revenue. On growth, Owlet, Inc. posted the faster year-over-year revenue change (29.6% vs 10.0%). AbbVie produced more free cash flow last quarter ($4.9B vs $-651.0K). Over the past eight quarters, Owlet, Inc.'s revenue compounded faster (34.2% CAGR vs 16.2%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Owlet, Inc. is a pediatric health technology firm that develops smart wearable monitoring products for infants, most notably its signature smart sock that tracks real-time heart rate, oxygen levels, and sleep metrics. It serves global consumer markets across North America, Europe, and Asia-Pacific, distributing products via direct-to-consumer e-commerce and partnered retail outlets, focused on supporting parental peace of mind and infant health safety.
ABBV vs OWLT — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $16.6B | $26.6M |
| Net Profit | $1.8B | $-9.2M |
| Gross Margin | 72.6% | 47.6% |
| Operating Margin | 27.3% | -18.4% |
| Net Margin | 10.9% | -34.6% |
| Revenue YoY | 10.0% | 29.6% |
| Net Profit YoY | 8354.5% | -1.5% |
| EPS (diluted) | $1.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.6B | $26.6M | ||
| Q3 25 | $15.8B | $32.0M | ||
| Q2 25 | $15.4B | $26.1M | ||
| Q1 25 | $13.3B | $21.1M | ||
| Q4 24 | $15.1B | $20.5M | ||
| Q3 24 | $14.5B | $22.1M | ||
| Q2 24 | $14.5B | $20.7M | ||
| Q1 24 | $12.3B | $14.8M |
| Q4 25 | $1.8B | $-9.2M | ||
| Q3 25 | $186.0M | $4.1M | ||
| Q2 25 | $938.0M | $-37.6M | ||
| Q1 25 | $1.3B | $3.0M | ||
| Q4 24 | $-22.0M | $-9.1M | ||
| Q3 24 | $1.6B | $-5.6M | ||
| Q2 24 | $1.4B | $-1.1M | ||
| Q1 24 | $1.4B | $3.3M |
| Q4 25 | 72.6% | 47.6% | ||
| Q3 25 | 66.4% | 50.6% | ||
| Q2 25 | 71.8% | 51.3% | ||
| Q1 25 | 70.0% | 53.7% | ||
| Q4 24 | 70.9% | 53.5% | ||
| Q3 24 | 70.9% | 52.2% | ||
| Q2 24 | 70.9% | 49.5% | ||
| Q1 24 | 66.7% | 44.4% |
| Q4 25 | 27.3% | -18.4% | ||
| Q3 25 | 12.1% | 3.8% | ||
| Q2 25 | 31.7% | -7.4% | ||
| Q1 25 | 28.0% | -12.7% | ||
| Q4 24 | -9.9% | -36.2% | ||
| Q3 24 | 26.5% | -21.8% | ||
| Q2 24 | 27.6% | -10.8% | ||
| Q1 24 | 22.7% | -39.0% |
| Q4 25 | 10.9% | -34.6% | ||
| Q3 25 | 1.2% | 12.9% | ||
| Q2 25 | 6.1% | -144.4% | ||
| Q1 25 | 9.6% | 14.3% | ||
| Q4 24 | -0.1% | -44.2% | ||
| Q3 24 | 10.8% | -25.4% | ||
| Q2 24 | 9.5% | -5.5% | ||
| Q1 24 | 11.1% | 22.2% |
| Q4 25 | $1.02 | — | ||
| Q3 25 | $0.10 | $-0.06 | ||
| Q2 25 | $0.52 | $-2.37 | ||
| Q1 25 | $0.72 | $0.11 | ||
| Q4 24 | $-0.03 | $-0.15 | ||
| Q3 24 | $0.88 | $-0.61 | ||
| Q2 24 | $0.77 | $-0.30 | ||
| Q1 24 | $0.77 | $-0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.3B | $35.5M |
| Total DebtLower is stronger | $58.9B | — |
| Stockholders' EquityBook value | $-3.3B | $19.0M |
| Total Assets | $134.0B | $85.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.3B | $35.5M | ||
| Q3 25 | $5.7B | $23.8M | ||
| Q2 25 | $6.5B | $21.8M | ||
| Q1 25 | $5.2B | $16.3M | ||
| Q4 24 | $5.6B | $20.2M | ||
| Q3 24 | $7.3B | $21.6M | ||
| Q2 24 | $13.2B | $15.4M | ||
| Q1 24 | $18.1B | $18.4M |
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | $2.1M | ||
| Q1 24 | $63.8B | $4.0M |
| Q4 25 | $-3.3B | $19.0M | ||
| Q3 25 | $-2.6B | $-54.1M | ||
| Q2 25 | $-183.0M | $-59.2M | ||
| Q1 25 | $1.4B | $-25.8M | ||
| Q4 24 | $3.3B | $-29.8M | ||
| Q3 24 | $6.0B | $-21.5M | ||
| Q2 24 | $6.8B | $-33.4M | ||
| Q1 24 | $8.0B | $-32.9M |
| Q4 25 | $134.0B | $85.6M | ||
| Q3 25 | $133.9B | $74.9M | ||
| Q2 25 | $137.2B | $63.5M | ||
| Q1 25 | $136.2B | $51.4M | ||
| Q4 24 | $135.2B | $49.5M | ||
| Q3 24 | $143.4B | $56.1M | ||
| Q2 24 | $141.9B | $45.9M | ||
| Q1 24 | $148.9B | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — | ||
| Q1 24 | 7.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.2B | $-452.0K |
| Free Cash FlowOCF − Capex | $4.9B | $-651.0K |
| FCF MarginFCF / Revenue | 29.4% | -2.5% |
| Capex IntensityCapex / Revenue | 2.0% | 0.7% |
| Cash ConversionOCF / Net Profit | 2.87× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.8B | $-11.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.2B | $-452.0K | ||
| Q3 25 | $7.0B | $-2.2M | ||
| Q2 25 | $5.2B | $-2.2M | ||
| Q1 25 | $1.6B | $-5.9M | ||
| Q4 24 | $7.0B | $3.0M | ||
| Q3 24 | $5.4B | $-7.5M | ||
| Q2 24 | $2.3B | $-3.4M | ||
| Q1 24 | $4.0B | $-3.4M |
| Q4 25 | $4.9B | $-651.0K | ||
| Q3 25 | $6.6B | $-2.2M | ||
| Q2 25 | $4.9B | $-2.3M | ||
| Q1 25 | $1.4B | $-5.9M | ||
| Q4 24 | $6.8B | $3.0M | ||
| Q3 24 | $5.2B | $-7.5M | ||
| Q2 24 | $2.0B | $-3.4M | ||
| Q1 24 | $3.8B | — |
| Q4 25 | 29.4% | -2.5% | ||
| Q3 25 | 42.1% | -6.8% | ||
| Q2 25 | 31.7% | -8.8% | ||
| Q1 25 | 10.5% | -28.1% | ||
| Q4 24 | 44.7% | 14.5% | ||
| Q3 24 | 35.9% | -33.9% | ||
| Q2 24 | 14.0% | -16.3% | ||
| Q1 24 | 31.3% | — |
| Q4 25 | 2.0% | 0.7% | ||
| Q3 25 | 2.4% | 0.0% | ||
| Q2 25 | 1.7% | 0.2% | ||
| Q1 25 | 1.8% | 0.0% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% | ||
| Q1 24 | 1.6% | 0.0% |
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | -0.52× | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | -1.96× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | -1.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
OWLT
| US | $22.7M | 85% |
| Non Us | $3.2M | 12% |
| Other | $651.0K | 2% |
